These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11845219)

  • 1. The in vivo regulation of pulsatile insulin secretion.
    Pørksen N
    Diabetologia; 2002 Jan; 45(1):3-20. PubMed ID: 11845219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile insulin secretion: detection, regulation, and role in diabetes.
    Pørksen N; Hollingdal M; Juhl C; Butler P; Veldhuis JD; Schmitz O
    Diabetes; 2002 Feb; 51 Suppl 1():S245-54. PubMed ID: 11815487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes.
    Pørksen N
    Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):9-14. PubMed ID: 12702002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure.
    Ritzel RA; Veldhuis JD; Butler PC
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E750-6. PubMed ID: 16278244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fasting on physiologically pulsatile insulin release in healthy humans.
    Juhl C; Grøfte T; Butler PC; Veldhuis JD; Schmitz O; Pørksen N
    Diabetes; 2002 Feb; 51 Suppl 1():S255-7. PubMed ID: 11815488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology.
    Schmitz O; Brock B; Hollingdal M; Juhl CB; Pørksen N
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S14-20. PubMed ID: 12703061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes.
    Lin JM; Fabregat ME; Gomis R; Bergsten P
    Diabetes; 2002 Apr; 51(4):988-93. PubMed ID: 11916916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of impaired pulsatile insulin release.
    Bergsten P
    Diabetes Metab Res Rev; 2000; 16(3):179-91. PubMed ID: 10867718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts.
    Pørksen N; Nyholm B; Veldhuis JD; Butler PC; Schmitz O
    Am J Physiol; 1997 Nov; 273(5):E908-14. PubMed ID: 9374676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.
    Satin LS; Butler PC; Ha J; Sherman AS
    Mol Aspects Med; 2015 Apr; 42():61-77. PubMed ID: 25637831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo.
    Gilon P; Ravier MA; Jonas JC; Henquin JC
    Diabetes; 2002 Feb; 51 Suppl 1():S144-51. PubMed ID: 11815474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
    Pørksen N; Grøfte B; Nyholm B; Holst JJ; Pincus SM; Veldhuis JD; Schmitz O; Butler PC
    Diabetes; 1998 Jan; 47(1):45-9. PubMed ID: 9421373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human insulin release processes measured by intraportal sampling.
    Pørksen N; Grøfte T; Greisen J; Mengel A; Juhl C; Veldhuis JD; Schmitz O; Rössle M; Vilstrup H
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E695-702. PubMed ID: 11832375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early changes in the function of pancreatic beta cells and insulin pulsatility as predictors of type 2 diabetes].
    Pørksen N
    Diabetes Metab; 1999 Dec; 25 Suppl 7():14-6. PubMed ID: 10746005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs.
    Larsen MO; Gotfredsen CF; Wilken M; Carr RD; Pørksen N; Rolin B
    Diabetologia; 2003 Feb; 46(2):195-202. PubMed ID: 12627318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in insulin secretion in type 2 diabetes mellitus.
    Guillausseau PJ; Meas T; Virally M; Laloi-Michelin M; Médeau V; Kevorkian JP
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S43-8. PubMed ID: 18640585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phasic insulin release and metabolic regulation in type 2 diabetes.
    Del Prato S; Marchetti P; Bonadonna RC
    Diabetes; 2002 Feb; 51 Suppl 1():S109-16. PubMed ID: 11815468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
    Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA
    Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter control of islet hormone pulsatility.
    Gylfe E; Tengholm A
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():102-10. PubMed ID: 25200303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.